Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • vasvale
    Member
    • Mar 2008
    • 29

    #1

    ssDNA in sample from targeted exon capture affecting quantification

    Has anybody experienced this problem:?

    I had too many clusters in a run and I’d like to ask if it ever happened to you: the DNA samples may have some single stranded DNA that is not quantified by the bioanalyzer nor Qubit (as they rely on intercalating dyes for dsDNA); I found out that using the kapa real time PCR kit (that picks up also ssDNA) the values are higher. The samples are 300 bp and in EB-tween 0.1%. After exon capture the elution from beads is alkaline and I wonder if that may be the reason why there some ssDNA.
  • vasvale
    Member
    • Mar 2008
    • 29

    #2
    I usually load the flow cell for a GAIIx run at 9 pM.

    Comment

    • Heisman
      Senior Member
      • Dec 2010
      • 534

      #3
      Are you using the Agilent kit? After elution the solution is alkaline, then you add in neutralization buffer, and then do PCR, which should cause everything to be double stranded.

      Comment

      • pmiguel
        Senior Member
        • Aug 2008
        • 2328

        #4
        Hi vasvale,
        I think most people have this issue to one extent or another. Amplicons derived from adapter-dimers or primer-dimers can (and do) anneal to real (sample library) amplicons at the adapter sites they share.

        Once annealed they will not be removed on the basis of molecular weight (gel cuts, Ampure isolation) unless these were to be done under strand denaturing conditions.

        So even if you do a gel cut and determine that you have a clean band in the desired size range using an Agilent DNA chip, you can be fooled because the small amplicons are "hitchhiking" on the backs of your normal library molecules.

        Then nearly all methods of determining the amplicon concentration of your sample will be confounded because they rely on the length determination done in the double stranded form.

        I would recommend that you assay some of your libraries on an Agilient RNA chip after strand denaturing them:

        Bridged amplification & clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)


        If you see very large peaks below 150 nt then it is likely that some of them are hitchhiking small amplicons.

        --
        Phillip

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...